Company: CGCT
Filing Date: 2025-01-29
Form Type: S-1
Source: 0001104659-25-006780
Chunk: 330

Company: Cartesian Growth Corp III
Filing Date: 2025-01-29
Form: S-1
Chunk 330
---
 per unit offering price was more arbitrary than would typically be the case if we were an
operating company. Among the factors considered in determining the initial public offering price were the history and prospects of companies
whose principal business is the acquisition of other companies, prior offerings of those companies, our management, our capital structure,
and currently prevailing general conditions in equity securities markets, including current market valuations of publicly traded companies
considered comparable to our company. We cannot assure you, however, that the price at which the units, Class A ordinary shares
or warrants will sell in the public market after this offering will not be lower than the initial public offering price or that an active
trading market in our units, Class A ordinary shares or warrants will develop and continue after this offering.

Listing

Currently, there is no public market for our
securities. We intend to apply to have our units, Class A ordinary shares and warrants listed on the Nasdaq Global Market tier of
Nasdaq. We expect that our units will be listed on Nasdaq under the symbol “ ” on or promptly after the date of this
prospectus. We expect the Class A ordinary shares and warrants comprising the units to begin separate trading on the 52nd day following
the date of this prospectus unless Cantor informs us of its decision to allow earlier separate trading, subject to our satisfaction of
certain conditions as described further herein. Once the securities comprising the units begin separate trading, we expect that the Class A
ordinary shares and warrants will be listed on Nasdaq under the symbols “ ” and “ ,” respectively.
However, we cannot guarantee that our securities will be approved for listing on Nasdaq.

Discounts

The following table shows the underwriting discounts
and commissions that we are to pay to the underwriters in connection with this offering. These amounts are shown assuming both no exercise
and full exercise of the underwriters’ over-allotment option.

|                                      |     | Per Unit       
 Without        
 Over-allotment |      |     | With           
 Over-allotment |      |     | Total          
 Without        
 Over-allotment |            |     | With           
 Over-allotment |            |
|:-------------------------------------|:----|:---------------|-----:|:----|:---------------|-----:|:----|:---------------|-----------:|:----|:---------------|-----------:|
| Underwriting                         
 Discounts and Commissions paid by us |     | $              | 0.65 |